Abstract
Radiofrequency (RF) cardiac ablation is the technique of choice for the treatment of asymptomatic arrhythmias [1]. It blocks the arhythmogenic signal via the isolation of the tissue regions with abnormal cardiac conduction. Due to the fact that ablation failure is often associated with inadequate lesion formation [2], we propose the use of a photonic biosensor to provide intraoperative feedback about the ablation’s viability. LAKK-M’s optical biosensor with UV-365 nm and Blue-450 nm [3] was used for recording the autofluorescence (AF) spectra in the range from 350 to 750 nm before and after RF ablation of the bovine myocardium.
© 2017 IEEE
PDF ArticleMore Like This
Christine P. Fleming MS, Hui Wang MS, Guy Amit MD, Kara J. Quan MD, and Andrew M. Rollins PhD
BMD88 Biomedical Optics (BIOMED) 2008
Johannes Swartling, Sara Palsson, and Stefan Andersson-Engels
TuF2 Biomedical Topical Meeting (BIOMED) 2002
Xiaowei Zhao, Ohad Ziv, Reza Mohammadpour, Benjamin Crosby, Walter J. Hoyt, Michael W. Jenkins, Christopher Snyder, Kenneth R. Laurita, and Andrew M. Rollins
TW4B.3 Clinical and Translational Biophotonics (Translational) 2020